SpanishDrug Discovery Network https://validator.w3.org/feed/docs/rss2.html Ponentes 2026 Exhibitors and Sponsors Mariusz Milewski Sonsoles Rodríguez-Arístegui Quantitative Live-Cell Analysis Of GPCR Signaling Dynamics Using Endogenous Bioluminescent Reporters: From Ligand Engagement To Downstream Effector Activation Poster’s virtual room 2026 XVIII SDDN Meeting 2026 XVIII SDDN Meeting 2026 2001: A CRO (Contract Research Organization) Odyssey Partnering Sponsorship 2026 Posters – Information 2026 Programme2026 XVIII SDDN Meeting 2026 Exhibitors and Sponsors 2026 Description Transforming Drug Discovery: Generative Models and Electrostatic Complementarity Screening for novel inhibitors of Mycobacterium tuberculosis dihydrofolate reductase using structure-based virtual screening Rucaparib as a repurposed therapeutic strategy for Parkinson’s Disease: in vitro and in vivo validation. Alberto Parras Rodríguez TRANSLATING OMICS-DRIVEN DRUG REPURPOSING INTO EXPERIMENTAL MODELS OF ALZHEIMER’S DISEASE Alba Miguens Gomez Juan Bautista Crespo García Ivan Cornella Taracido Alba Mosteiro Couso Álvaro Ferrer Franco How and when to protect Drug Discoveries (DDs) through patents. Dialogue with Q&A between a researcher in DD and a patent attorney Uncovering Novel Therapeutic Candidates for Alzheimer’s Disease Through Integrative Omics-Based Drug Repurposing Jokin Jose Manuel Lopez Vilariño Paula Dominguez Lacueva página de prueba Carme Serra Comas Ivan Marcos-Campos Juan Francisco Simon Silva Lara Garcia Varela Stefano Benvegnu Leticia Ferreiro Massimiliano Dal Rio Sandra Elena Caballero Sánchez Andrea Zapater Amarlig Ferrigni Alberto Parras Rodríguez CARME PAMPIN Maria Jurado Anna Llebaria I Fabrias JULIE MASSE David Moreira Álvarez Cristina Val Home